Loading...
Loading...
By MBN Staff - Mon, 01/19/2026 - 08:46
Multicare and KalVista partner to expand access to the first oral on-demand treatment for hereditary angioedema (HAE) across Latin America.
https://mexicobusiness.news/tag/drug-development
More Health
By MBN Staff - Mon, 12/01/2025 - 17:37
Therapeutics company Generate:Biomedicines will begin global Phase 3 trials of GB-0895, an AI-designed antibody for severe asthma.
By MBN Staff - Mon, 11/24/2025 - 12:20
WHO’s GAP-f outlines new steps to expand access to age-appropriate medicines as global demand for pediatric treatments grows.
By MBN Staff - Wed, 11/12/2025 - 16:16
WHO warns that stalled funding and unequal access threaten global progress toward ending tuberculosis by 2030.
By Enrique Remezal - Thu, 10/16/2025 - 09:00
Open innovation, regulatory simplification, and talent management are key for investment and pharma growth in Latin America, writes Enrique Remezal.
By Aura Moreno - Mon, 09/08/2025 - 09:06
Glenmark initiates a multi-country Phase 3 trial of Envafolimab in resectable Stage III non-small cell lung cancer, with enrollment starting in India.
By Diego Valverde - Thu, 08/21/2025 - 13:32
This week, Mexico strengthened AI and cloud infrastructure with ODATA’s new data center. This and more in your weekly roundup!
By Sofía Garduño - Thu, 08/14/2025 - 10:42
This week, Grupo OMNI buys Marzam, Boehringer expands its Xochimilco plant, and Novartis reports positive Phase III results for Sjögren’s drug.
By MBN Staff - Wed, 08/13/2025 - 10:08
Dräger’s Atlan A350 anesthesia workstation series earns US DoD cybersecurity certification, securing patient data in operating rooms.
By MBN Staff - Wed, 08/13/2025 - 09:02
Novartis reports Phase III success for ianalumab, a potential first targeted treatment for Sjögren’s disease.
